Hyphens Pharma Debuts Breakthrough Eczema Hand Balm
Company Announcements

Hyphens Pharma Debuts Breakthrough Eczema Hand Balm

Hyphens Pharma International Ltd. (SG:1J5) has released an update.

Hyphens Pharma International Ltd., a leader in specialty pharmaceuticals and consumer healthcare, proudly unveils Ceradan® Advanced Hand Balm, a novel solution specifically formulated to combat hand eczema. Developed in collaboration with A*STAR, the balm features a unique patented pH control technology and a ceramide-dominant formula to effectively manage and soothe symptoms. Aimed at addressing the needs of healthcare workers disproportionately affected by hand eczema, the product marks a leap forward in skin health management.

For further insights into SG:1J5 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Singapore Auto-Generated NewsdeskHyphens Pharma Clinches Prestigious Governance Award
TipRanks Singapore Auto-Generated NewsdeskHyphens Pharma CEO Resigns, Leaves Growth Legacy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App